沙特专家对获得血友病的共识 A诊断和管理
Abdulkareem M Almomen1, Hazza A Alzahrani2, Hussein H AlSaeed3
1Department of Pathology, College of Medicine, King Saud University, Riyadh, KSA.
获得的血友病A是一种罕见的出血障碍,需要及时诊断和管理,以防止严重的并发症. 这一共识为沙特阿拉伯王国 (KSA) 的从业人员提供了必要的指导方针,以改善患者的治疗结果.
科学领域:
- 血液学 血液学 血液学
- 内部医学 内部医学
背景情况:
- 获得性血友病A是一种罕见的自身免疫性疾病,大约影响100万分之一的人.
- 由于缺乏医生的专业知识,延迟诊断很常见,导致长时间的低诊断和潜在的危及生命的出血事件.
研究的目的:
- 为获得的血友病A.建立全面的诊断和管理指南.
- 为沙特阿拉伯王国 (KSA) 的所有医疗保健从业人员提供必要的知识,以管理这种罕见的疾病.
主要方法:
- 一个由血液学专家组成的小组制定共识声明.
- 利用一个明确的系统过程来识别共识和分歧的领域.
主要成果:
- 该共识为诊断获得的血友病A提供了实用指南,详细说明了临床表现和出血特征.
- 它概述了管理策略,包括诊断和治疗方式,特别针对KSA环境.
结论:
- 这份共识声明旨在弥合医生,特别是非专家之间的知识差距,以诊断和管理获得的血友病A.
- 它赋予沙特阿拉伯的从业者以专家驱动的建议来确保获得血友病A患者的及时和有效护理.
更多相关视频
13:12Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays
Published on: April 4, 2011
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
相关概念视频
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
